| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/29/2009 | US20090029348 Detecting an anti-hepatitis C virus (HCV) antibody; combine a biotin-avidin magnifying system; sensitive and specific |
| 01/29/2009 | US20090029347 Method for Identifying Multiple Analytes Using Flow Cytometry |
| 01/29/2009 | US20090029346 Detection of human papilloma virus |
| 01/29/2009 | US20090029345 Modulating skeletal muscle |
| 01/29/2009 | US20090029344 Compositions and assays utilizing ADP or phosphate for detecting protein modulators |
| 01/29/2009 | US20090029343 Methods for isolation and analysis of sialylated and phosphorylated peptides |
| 01/29/2009 | US20090029002 Gene encoding glycogen synthesis initiator and use thereof |
| 01/29/2009 | US20090029001 Gene encoding protein responsible for flocculation property of yeast and use thereof |
| 01/29/2009 | US20090028900 West nile viruses with mutations in the 3' terminal stem and loop secondary structure for use as live virus vaccines |
| 01/29/2009 | US20090028892 Ostertagia Vaccine |
| 01/29/2009 | US20090028891 Chlamydia Antigens and Uses Thereof |
| 01/29/2009 | US20090028890 encodes an HIV-1 MA polypeptide myristate binding site; capable of selectively eliciting a substantially th-1 immune response to HIV-1; vaccine |
| 01/29/2009 | US20090028888 Cancer Antigen Mage-A9 and Uses Thereof |
| 01/29/2009 | US20090028887 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/29/2009 | US20090028882 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| 01/29/2009 | US20090028876 Methods of modifying cd11c+ dendritic cell development to form osteoclasts functional in the bone environment |
| 01/29/2009 | US20090028866 USE OF CCR9, CCL25/TECK, AND NITEGRIN alpha4 IN DIAGNOSIS AND TREATMENT OF MELANOMA METASTASIS IN THE SMALL INTESTINE |
| 01/29/2009 | US20090028864 L-amino acid oxidase with cytotoxic activity from aplysia functata |
| 01/29/2009 | US20090028863 Markers for diagnosis of cancer and its use |
| 01/29/2009 | US20090028861 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes |
| 01/29/2009 | US20090028860 Use of IL-17 Expression to Predict Skin Inflammation; Methods of Treatment |
| 01/29/2009 | US20090028852 Roles For Dual Endothelin-1/Angiotensin II Receptor (DEAR) In Hypertension and Angiogenesis |
| 01/29/2009 | US20090028847 Multiple myeloma and al amyloid immunotherapy targeting immunoglobulin light chains and uses thereof |
| 01/29/2009 | US20090028845 obtaining a sample from the subject's frontal cortex, analyzing the level of expression of ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) gene, wherein reduced levels of expression of UCH-L1 gene compared to controls is diagnostic of DLB; Alzheimer's Disease and Parkinson's disease |
| 01/29/2009 | US20090028844 Galnts as modifiers of the igfr pathway and methods of use |
| 01/29/2009 | US20090028843 IgA allelic variants |
| 01/29/2009 | US20090028836 Stem and progenitor cell expansion by evi, evi-like genes and setbp1 |
| 01/29/2009 | US20090028835 Human transcriptome corresponding to human oocytes and use of said genes or the corresponding polypeptides to trans-differentiate somatic cells |
| 01/29/2009 | US20090028831 Stem cell regulator, compositions and methods of use |
| 01/29/2009 | US20090028804 AhR mediators |
| 01/29/2009 | US20090028792 Nano-particle surface modification |
| 01/29/2009 | US20090028413 System and method employing photokinetic techniques in cell biology imaging applications |
| 01/29/2009 | US20090026565 Optical Module |
| 01/29/2009 | US20090026092 Enzymatic Biosensors With Enhanced Activity Retention For Detection Of Organic Compounds |
| 01/29/2009 | US20090026091 Electrochemical Test Strip |
| 01/29/2009 | DE102007036404A1 Nachweis der Platinresistenz Proof of platinum resistance |
| 01/29/2009 | DE102007035659A1 Immortalisierte Keratinozyten-Zelllinie und Verfahren zur Messung von protektiven Mitteln An immortalized keratinocyte cell line and method for measuring protective agents |
| 01/29/2009 | DE102007035634A1 Security document e.g. identity card comprises a monolithic laminate card body, which is produced out of layers and has first and second identification features, which enable an identification and allocation to a living organism |
| 01/29/2009 | DE102007035238A1 Biologisches Effektmonitoring mittels transgener Hydra Biological effect monitoring using transgenic Hydra |
| 01/29/2009 | DE102007034993A1 Lösliches Cadherin 17 für die Diagnose und Risikostratifizierung von Darmtumor oder Darmkrebs Soluble cadherin 17 for the diagnosis and risk stratification of bowel cancer or colon cancer |
| 01/29/2009 | CA2694561A1 A microbiological detection method |
| 01/29/2009 | CA2694349A1 Method for detecting disease markers |
| 01/29/2009 | CA2694085A1 Electrochemical test strip |
| 01/29/2009 | CA2694045A1 Electrochemical analyte detection apparatus and method |
| 01/29/2009 | CA2694007A1 Determining a nucleic acid sequence imbalance |
| 01/29/2009 | CA2693481A1 A novel population of hepatocytes derived via definitive endoderm (de-hep) from human blastocysts derived stem cells |
| 01/29/2009 | CA2693451A1 Combined method and kit for the sequential measurement of (1) the enzymatically active fraction and (2) the total amount of an enzyme |
| 01/29/2009 | CA2693081A1 Diagnosing fetal chromosomal aneuploidy using genomic sequencing |
| 01/29/2009 | CA2690541A1 Biomarkers for pre-diabetes, cardiovascular diseases, and other metabolic-syndrome related disorders and methods using the same |
| 01/28/2009 | EP2019148A1 Gene mapping method using microsatellite genetic polymorphism markers |
| 01/28/2009 | EP2019139A1 WT1 interacting protein WTIP |
| 01/28/2009 | EP2019136A1 Method for detecting or quantifying wheat endogenous dna and method for determining contamination rate of genetically modified wheat in test sample |
| 01/28/2009 | EP2019115A2 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species |
| 01/28/2009 | EP2018622A2 Systems and devices for sequence by synthesis analysis |
| 01/28/2009 | EP2018568A1 Hdl cholesterol sensor using selective surfactant |
| 01/28/2009 | EP2018564A1 Detection method for influenza viruses |
| 01/28/2009 | EP2018443A2 Compositions and methods for inhibiting expression of ikk-b gene |
| 01/28/2009 | EP2018442A2 Methods and compositions for the diagnosis and treatment of cancer |
| 01/28/2009 | EP2018441A2 Tagged microorganisms and methods of tagging |
| 01/28/2009 | EP2018440A1 NMU-GHSR1b/NTSR1 ONCOGENIC SIGNALING PATHWAY AS A THERAPEUTIC TARGET FOR LUNG CANCER |
| 01/28/2009 | EP2018439A1 Personalizing cancer chemotherapy based on methylation and germ-line mutational analysis of brca-1 |
| 01/28/2009 | EP2018438A1 Electronic biosensor arrangement |
| 01/28/2009 | EP2018425A1 Method for extracting deoxyribonucleic acids (dna) from microorganisms possibly present in a blood sample |
| 01/28/2009 | EP2018188A2 Real-time detection of influenza virus |
| 01/28/2009 | EP1880025A4 Multiplex branched-chain dna assays |
| 01/28/2009 | EP1861497A4 Protein and its use in diagnosing alzheimer's disease |
| 01/28/2009 | EP1815006A4 Inhibitors of biotin protein ligase |
| 01/28/2009 | EP1720999B1 Methods for detection of microbial contaminants in peritoneal dialysis solutions |
| 01/28/2009 | EP1391505B1 Stem cells and method of separating the same |
| 01/28/2009 | EP1379658B1 Antimicrobial peptides and methods of use |
| 01/28/2009 | EP1343869B1 Detection of nucleic acid differences using combined endonuclease cleavage and ligation reactions |
| 01/28/2009 | EP1340075B1 Establishment of biological cut-off values for predicting resistance to therapy |
| 01/28/2009 | EP1187939B1 Detection of hiv-1 by nucleic acid amplification |
| 01/28/2009 | EP0675953B1 Soluble peptides having constrained, secondary conformation in solution and method of making same |
| 01/28/2009 | CN201188104Y High flux test chip |
| 01/28/2009 | CN201188085Y Visual measurement colour comparison card for choline esterase |
| 01/28/2009 | CN201186924Y Apparatus for preparing cell chip |
| 01/28/2009 | CN101356436A Treatment and diagnosis of obligate intracellular pathogens |
| 01/28/2009 | CN101356288A Methods using pores |
| 01/28/2009 | CN101356287A Methods and compositions for the assessment of cardiovascular function and disorders |
| 01/28/2009 | CN101356286A Diagnostics and therapeutics for cardiovascular disorders |
| 01/28/2009 | CN101356285A Methods for identification of merle gene |
| 01/28/2009 | CN101356284A Aptamer medicinal chemistry |
| 01/28/2009 | CN101356283A Enzymatic methods for measuring plasma and tissue sphingomylelin and phosphatidylcholine |
| 01/28/2009 | CN101356282A Method and apparatus for enhanced detection of toxic agents |
| 01/28/2009 | CN101356269A Methods for expression and purification of recombinant human growth hormone |
| 01/28/2009 | CN101356184A Methods for assessing patients with acute myeloid leukemia |
| 01/28/2009 | CN101354399A Multifunctional dry plate test board and preparation method and application thereof |
| 01/28/2009 | CN101354391A Method of detecting bias in enzyme electrode measurements |
| 01/28/2009 | CN101354354A Color development liquid for peroxidase mensuration and preparation method thereof |
| 01/28/2009 | CN101354347A Methylation quantitative detection method of APC gene in human plasma |
| 01/28/2009 | CN101354346A Methylation quantitative detection method of RASSFIA gene in human plasma |
| 01/28/2009 | CN101354345A Reagent kit for detecting children asthma genetic susceptibility |
| 01/28/2009 | CN101354344A Genetic information and health evaluating management |
| 01/28/2009 | CN101354343A Reagent kit for detecting adiposity genetic susceptibility |
| 01/28/2009 | CN101354342A Reagent kit for detecting cigarette and wine damnification genetic susceptibility |
| 01/28/2009 | CN101354341A Reagent kit for detecting female tumor disease genetic susceptibility |
| 01/28/2009 | CN101354340A Reagent kit for detecting metabolism disease genetic susceptibility |
| 01/28/2009 | CN101354339A Reagent kit for detecting male tumor disease genetic susceptibility |
| 01/28/2009 | CN101354338A Reagent kit for detecting heart brain disease genetic susceptibility |